Synthesis of novel pyrazolyl tetrazoles as selective COX-2 inhibitors

By Swetha Kolli   Parameshwar Ravula   Reddy B.   babu V.  

Medicinal Chemistry Research, Vol. 22, Iss. 10, 2013-10 ,pp. : 4886-4892

Springer Publishing Company

Access to resources Recommend Favorite

Review of the selective COX-2 inhibitors celecoxib and rofecoxib: focus on clinical aspects

By  

Canadian Journal of Emergency Medicine, Vol. 4, Iss. 4, 2002-07 ,pp. : 268-275

Cambridge University Press

Access to resources Recommend Favorite

Long‐term use of proton pump inhibitors, dose–response relationship and associated risk of ischemic stroke and myocardial infarction

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 3, 2018-03 ,pp. : 268-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implementation of NICE guidance on Cox-II selective inhibitors

By Arnold K.  

Journal of Clinical Excellence, Vol. 4, Iss. 3, 2002-07 ,pp. : 315-317

Radcliffe Press

Access to resources Recommend Favorite

Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization

By Sun Shawn X.   Lee Kwan Y.   Bertram Carl T.   Goldstein Jay L.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1859-1866

Informa Healthcare

Access to resources Recommend Favorite